Trials / Completed
CompletedNCT03670043
Tolerance & Responsiveness Improvement for Metformin (TRIM)
Tolerance & Responsiveness Improvement for Metformin (TRIM): Open-label, Parallel-group Randomized Trial, Phase 4
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- West Side Institute for Science and Education · Academic / Other
- Sex
- Male
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The overall goal is to explore the hypothesis that prebiotic fiber Psyllium will ameliorate diarrhea in African American men (AAM) with Type2 Diabetes Mellitus (T2D).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Psyllium powder | To evaluate whether Psyllium will alleviate diarrhea |
| DRUG | Metformin Extended Release Oral Tablet | Metformin Extended Release Oral Tablet is standard of care for diarrhea in patients taking metformin |
Timeline
- Start date
- 2019-03-19
- Primary completion
- 2020-10-15
- Completion
- 2021-08-15
- First posted
- 2018-09-13
- Last updated
- 2021-09-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03670043. Inclusion in this directory is not an endorsement.